Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies
暂无分享,去创建一个
M. Griesshammer | S. Verstovsek | P. Guglielmelli | F. Passamonti | G. Saydam | T. Masszi | S. Durrant | Mark M. Jones | J. Kiladjian | B. Gadbaw | Mahmudul Khan | H. Zhen | Jingjin Li | Julian Perez Ronco